HM hospitales
Madrid, 28015, Spain
NCT Number: NCT06301139
In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops.
Looking for future studies?
Notify Me6 week–3 month
All sexes
Interventional
Not applicable
Madrid, 28015, Spain
Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this randomized controlled pilot study, the effect on comfort during usage of goat-milk based infant formula is studied. Twenty formula fed infants (aged between 6 weeks and 3 months) who experience mild discomfort will receive goat milk-based infant formula (GMF) or cow's mik based infant formula supplemented with probiotics lactobacillus reuteri drops (CMFp). The infants will be assessed by a local paediatricians using the Cow's Milk-related Symptom Score (CoMiSS). This is a fast, non-invasive and easy-to-use and validated questionnaire to assess infant's reaction to proteins found in cow's milk. The higher the score, the more sensitive the child is to cow's milk proteins, the maximum score is 33 points. Infants with a CoMiSS Score between 6 and 12 will be enrolled in this study. It is expected that infants will have a better response to GMF, which will result in a decrease of the CoMiSS Score after a 2 weeks intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infant formula based on goat milk for 4 weeks at volume depending on the infant
Infant formula based on cow's milk with probiotic Lactobacillus reuteri drops for 4 weeks at volume depending on the infant
Time frame: 0-2 weeks
Difference in Cow's Milk related Symptom Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 14 days of intervention.
Time frame: 0-4 weeks
Difference in Cow's Milk-related Symptoms Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in parental stress measured by Parental Stress Index-Short Form (PSI-SF: score ranges from 15% to 100% with higher scores indicating more stress) at baseline, after 5 days, after 9 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in parental quality of life measured by World Health Organization Quality Of Life questionnaire - short version (WHOQOL-BREF: score ranges from 0 to 100 with higher scores indicating better quality of life ) at baseline, after 5 days, after 9 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in weight (grams) at baseline, after 14 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in length (cm) at baseline, after 14 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in weight-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in length-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.
Time frame: 0-4 weeks
Difference in weight-for-length z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention.
Ausnutria Hyproca B.V.
Industry
Clinical Trial to Assess Improvement of Digestive Symptoms With Goat's Milk Infant Formula.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06286865
Digestive System Diseases, Gastrointestinal Diseases
Tromsø, Troms, Norway
View Trial DetailsNCT06159088
Digestive System Diseases, Gastrointestinal Diseases
Jinhua, Zhejiang, China
View Trial DetailsNCT01697397
Colonic Diseases, Colonic Diseases, Functional
Mountain View, California, United States
View Trial DetailsNCT05298774
Digestive System Diseases, Gastrointestinal Diseases
New Haven, Connecticut, United States
View Trial Details